Alexander Nolte

Insider Reports History

Location: Waltham, MA
Signature: /s/ Brian J. Shea, Attorney-in-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alexander Nolte:

Form 4 holding Chief Accounting Officer

Syndax Pharmaceuticals Inc

Security class: Stock Options (Right to buy)
Shares / value: 17,000
Estimated value: $439,343
Report date: 02 Feb 2023
Price: $25.84
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Alexander Nolte

3

Oncorus, Inc.

Report period: 09 May 2023
Transactions: 0
Transaction value: $0
Filing time: 22 May 2023, 17:00
Role: Interim CFO
Next action: Open filing details

4 SNDX

Syndax Pharmaceuticals Inc

Report period: 02 Feb 2023
Transactions: 1
Transaction value: +$485,350
Filing time: 03 Feb 2023, 15:58
Role: Chief Accounting Officer
Next action: Open filing details

4 SNDX

Syndax Pharmaceuticals Inc

Report period: 01 Feb 2022
Transactions: 3
Transaction value: +$469,576
Filing time: 03 Feb 2022, 16:31
Role: Chief Accounting Officer
Next action: Open filing details

3 SNDX

Syndax Pharmaceuticals Inc

Report period: 22 Oct 2021
Transactions: 0
Transaction value: $0
Filing time: 04 Nov 2021, 16:03
Role: Chief Accounting Officer
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .